October 26, 2021
Article
From the Chairman
New research in blood cancer includes new treatment options for acute myeloid leukemia and a novel therapy using BK virus-specific T cells to treat BK virus-associated hemorrhagic cystitis.
October 25, 2021
Article
Speaking Out
Dr. Gabriela Hobbs offers insight into a rare cancer, myeloproliferative neoplasms, to help patients learn more during their treatment journey.
October 21, 2021
Article
Research News and Updates
A new T-cell therapy can be highly effective in treating BKV-associated hemorrhagic cystitis while minimizing side effects.
October 20, 2021
Article
Features
An abundance of clinical trials is giving patients with acute myeloid leukemia (AML) hope for a better future.
October 19, 2021
Article
Editor's Page
Engineered cell technology is an example of ingenuity that brings together cutting-edge laboratory science and clinical trials to address aggressive cancers.
October 18, 2021
Article
Feature
After receiving a diagnosis of multiple myeloma, a patient relied on the Multiple Myeloma Research Foundation for information and is becoming part of the conversation.
October 16, 2021
Article
Research News and Updates
A fixed-duration treatment regimen may result in better outcomes and less time in the hospital for patients with CLL.
October 11, 2021
Article
Features
Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.
October 07, 2021
Article
Feature
Caregivers of patients with cancer may face financial toxicity and stress — with little time to take care of themselves.
Subcutaneous Keytruda Plus Berahyaluronidase Alfa Combo Meets Phase 3 Trial End Points in NSCLC
UGN-102 Shows Promising Treatment Responses in Recurrent Bladder Cancer
Feelings of Gratitude in November as a Colon Cancer Survivor
Aerobic Exercise May Improve Self-Reported Cognitive Function in Breast Cancer